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Abstract
CXCR4 regulates cell proliferation, enhances cell survival and induces chemotaxis, yet molecular mechanisms underlying its
signaling remain elusive. Like all other G-protein coupled receptors (GPCRs), CXCR4 delivers signals through G-protein-
dependent and -independent pathways, the latter involving its serine-rich cytoplasmic tail. To evaluate the signaling and
biological contribution of this G-protein-independent pathway, we generated mutant mice that express cytoplasmic tail-
truncated CXCR4 (DT) by a gene knock-in approach. We found that DT mice exhibited multiple developmental defects, with
not only G-protein-independent but also G-protein-dependent signaling events completely abolished, despite DT’s ability
to still associate with G-proteins. These results reveal an essential positive regulatory role of the cytoplasmic tail in CXCR4
signaling and suggest the tail is crucial for mediating G-protein activation and initiating crosstalk between G-protein-
dependent and G-protein-independent pathways for correct GPCR signaling.
Citation: Cronshaw DG, Nie Y, Waite J, Zou Y-R (2010) An Essential Role of the Cytoplasmic Tail of CXCR4 in G-Protein Signaling and Organogenesis. PLoS
ONE 5(11): e15397. doi:10.1371/journal.pone.0015397
Editor: Derya Unutmaz, New York University, United States of America
Received August 10, 2010; Accepted September 6, 2010; Published November 19, 2010
Copyright:  2010 Cronshaw et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the DANA Foundation (CU-51912001), the Sandler Program for Asthma Research (SPAR 04-0179), and the Irene
Diamond Fund (SHRI 1703) to Y.-R. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yzou@nshs.edu
¤a Current address: Department of Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
¤b Current address: Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York, United States of America
Introduction
CXCR4 is a seven-transmembrane GPCR for the chemokine,
CXCL12. Both CXCR4 and CXCL12 are broadly expressed by
cells of multiple tissues and play an indispensable role in
embryogenesis [1]. Genetic ablation of CXCR4 or CXCL12
leads to embryonic lethality, as a result of defects in cardiogenesis,
vascular development, hematopoiesis, and the CNS [2–6]. In
adulthood, CXCR4 and CXCL12 have been implicated in
pathogenesis of autoimmune diseases and tumor metastasis [7–
10]. However, the precise molecular mechanisms that underlie
these diverse physiological and pathological functions remain
obscure.
Like the majority of GPCRs, CXCR4 contains a highly
conserved DRY motif (Asp-Arg-Tyr) located in the second
intracellular loop. Extensive studies using rhodopsin and adren-
ergic receptors as models have established a general paradigm for
GPCR activation. It proposes that ligation of GPCR triggers
protonation of the Asp residue in the DRY motif, inducing
conformational changes of the GPCR and activation of the
interacting G proteins [11,12]. Mutation of the DRY motif of
chemokine receptors prevents ligand-induced activation of the
pertussis toxin (PTX)-sensitive Gai proteins and abolishes
generation of second messengers and chemotaxis, indicating a
pivotal role of the DRY motif in G-protein mediated signaling
[13–16]. Increasing evidence shows GPCRs may also exert
biological effects independent of G-protein function. The C-
terminal (CT) tail of GPCRs is rich in serines and threonines, and
truncation of the tail of several chemokine receptors abrogates
ligand-activated receptor phosphorylation, demonstrating that the
tail of these receptors is the only phosphorylation target of GPCR
kinases (GRKs) [17,18]. Phosphorylated GPCR tail binds to b-
arrestins, leading to rapid internalization and desensitization of the
ligand-activated receptor [19,20]. In addition to mediating
receptor internalization, b-arrestins also serve as scaffold proteins,
recruiting Src family tyrosine kinases to the phosphorylated
GPCRs and consequently activate MAP kinases [21]. Given that
GPCRs may deliver signals through the DRY motif and its
cytoplasmic tail, it is important to determine whether the DRY
motif and the tail of CXCR4 act as independent signaling
transduction modules that carry out distinct cellular functions.
The functional importance of the CT tail of CXCR4 has been
underscored by identification of truncating mutations of CXCR4
in patients with WHIM (warts, hypogammaglobulinemia, immu-
nodeficiency, and myelokathexis) syndrome. WHIM patients carry
autosomal dominant mutations in Cxcr4 that eliminate a part of
the serine-rich CT tail [22]. Considerable studies have been
conducted using mutant cells from WHIM patients or a variety of
cell lines transfected with truncational mutants of CXCR4 to
investigate WHIM pathogenesis. While all these data show that
deletion of the tail impairs ligand induced receptor internalization,
the biochemical and cellular responses, however, seem to be highly
variable in these in vitro systems, with variations in MAPK
activation and chemotaxis [23–28]. These discrepancies could be
attributed to different expression levels of the transgenic CXCR4
as well as to different signaling machinery available in the utilized
cell lines. To overcome these problems, we generated mutant mice
that express tail-truncated CXCR4 by a ‘‘knock-in’’ approach and
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biochemical functions of the CXCR4 tail under physiological
conditions. Results of the present study reveal that truncation of
the CT tail of CXCR4 not only obliterates G-protein independent
signaling pathways mediated by tail-associated factors, but also
prevents signaling through Gai, resulting in similar developmental
defects as seen in CXCR4-null mice.
Results
Generation of CXCR4-DT mice
The cytoplasmic tail of CXCR4 contains 16 serine residues
which are the putative targets of GRKs. In order to evaluate the
precise biological functions mediated by the CT tail of CXCR4 we
removed the last 42 amino acids from CXCR4 (aa 318–359),
thereby completely eliminating the sequences that confer GRK
activity and b-arrestin recruitment (Fig. 1A, mutant CXCR4 is
hereafter denoted as DT). To ensure a physiological expression of
DT, we generated ‘‘knock-in’’ mice (Fig. S1). Our results showed
that DT was expressed at an identical level to that of wildtype
(WT) CXCR4 on myeloid cells in embryonic day (E) 18.5 fetal
liver (Fig. 1B). Furthermore, DT bound CXCL12 with an affinity
similar to that of WT CXCR4 (Fig. 1C). In this report, we refer to
the mutant mice carrying the CXCR4 tail-truncated allele as ‘‘DT
mice’’.
DT mutants phenocopy the developmental defects of
CXCR4-null mice
Previous reports have shown that CXCR4-null mice exhibit
multiple developmental defects and die perinatally [3,4,29]. Such
an embryonic lethal phenotype was not rescued in DT mice,
however, unlike CXCR4-null mice of which only 50% survived till
E17.5 and all with reduced body sizes [4], DT embryos were
present at Mendelian ratios till E18.5 with grossly normal body
sizes and morphology (data not shown).
To determine to what extent the DT mutation affected
organogenesis, we examined those organs of which formation
was critically dependent on CXCR4. We found that, similar to
that observed in CXCR4-null mice, DT mice lacked large vessels
in the gastrointestinal area (Fig. 2A); had displaced cells of the
external granule layer (EGL) in the cerebellum (Fig. 2B); defective
B cell genesis (Fig. 2C) and severely impaired bone marrow (BM)
myelopoiesis (Fig. 2D). These results together indicate that,
although the overall impact on animal development is relatively
milder, the DT mutation imposes almost identical effects as the
CXCR4-null mutation on the development of neural, vascular and
hematopoietic systems.
SinceDT micewereembryoniclethal,we generatedCXCR4
f/DT
mice and crossed them to transgenic CD19-Cre (B cell specific) and
ROSA
ET2-CRE mice (tamoxifen induced) to delete the floxed Cxcr4
allele and conditionally express DT in specific lineages of cells. We
also established pro-B cell lines by Abelson virus transformation for
in vitro studies to determine cellular and biochemical functions of the
CXCR4 tail.
The CXCR4 tail is critical for CXCL12-induced chemotaxis
but dispensable for integrin-mediated adhesion
At the late gestation, the primary site of hematopoiesis shifts
from the fetal liver (FL) to BM. This process is dependent on
CXCR4-mediated migration of hematopoietic stem cells (HSCs)
[2,4,29]. Since myelopoiesis was relatively normal in the FL but
defective in BM of DT mice (Fig. 2D), it was conceivable that the
DT mutation impaired BM homing of hematopoietic cells. To
determine whether the CXCR4 tail was required for chemotaxis,
we measured the chemotactic response of DT pro-B cells toward
CXCL12 by a transwell assay. We found that while 15–20% of
WT pro-B cells underwent chemotaxis toward CXCL12, less than
2% of DT cells migrated under the same condition (Fig. 3A).
Abolishment of CXCL12-induced chemotaxis was also found for
the FL hematopoietic cells (Fig. 3B), demonstrating that the
CXCR4 tail is essential for CXCL12-mediated chemotaxis.
We have shown previously that CXCR4 signaling promotes
retention of B-cell precursors in the BM [30], presumably through
VCAM-1/VLA-4 mediated firm adhesion [31,32] and lack of
CXCR4 leads to the release of these precursors into the periphery.
To examine whether DT is still able to facilitate the retention of
B-cell precursors in the BM, we analyzed B-cell subsets in
peripheral blood and spleen of CD19-Cre- CXCR4
f/DT (WT),
CD19-Cre+ CXCR4
f/DT (DT), and CD19-Cre+ CXCR4
f/f mice
(CXCR4 null) by flow cytometry. In WT animals, B cell
precursors (B220
loIgM
2) were barely detectable in PB (Fig. S2).
When Cxcr4 was deleted, a substantial amount of B cell precursors
were released from the BM to the periphery (Fig. 4A) and this
population was significantly reduced in the in the blood and spleen
of DT mice, suggesting that DT partially restored BM retention
(Fig. 4A and Fig. S2).
To directly examine whether the cytoplasmic tail of CXCR4
was required for triggering integrin-mediated cell adhesion, we
decided to test in vitro the ability of DT to promote B cell adherence
to VCAM-1. To exclude the possible interference from CXCR7,
the other receptor for CXCL12, we used DT, CXCR4-null and
WT pro-B cells in a static adhesion assay. These pro-B cells have
an identical cell-surface level of VLA-4 (receptor for VCAM-1) but
do not express CXCR7 (Fig. S3). As shown in Fig. 4B, WT pro-B
cells exhibited a 4-fold increase in VCAM-1 adhesion after
CXCL12 stimulation, whereas CXCR4-null cells exhibited only
basal VCAM-1-binidng activity. Notably, CXCL12 induced
adherence of DT cells to VCAM-1 was comparable to that of
WT (Fig. 4B). These results indicate that tail-truncated CXCR4 is
still able to mediate inside-out signaling that activates VLA-4.
Interestingly, the adhesion of WT and DT mutant pro-B cells to
VCAM-1 was not affected by PTX pretreatment (Fig. S4),
suggesting that activation of VLA-4 was independent of Gai
signals.
CT tail deletion abolishes b-arrestin binding and impairs
CXCR4 internalization
Whether the tail of CXCR4 is the only cytoplasmic domain that
recruits b-arrestins remains controversial. Whereas a number of
studies have shown that CXCR4 is primarily associated with b-
arrestins through its CT tail [27,33], others can co-IP tail-
truncated CXCR4 with b-arrestins [26,34] or detect it co-localized
with b-arrestins by microscopy [25]. To detect the interaction
between b-arrestins and DT, we performed a Tango assay [35] in
which ligand-induced rapid and transient interaction between
CXCR4 and b-arrestins is converted into an accumulative
transcriptional response (Fig. 5A). We found that reporter cells
expressing WTCXCR4-tTA exhibited an increased luciferase
activity after CXCL12 stimulation. In contrast, such CXCL12-
induced luciferase gene activation was not detected in
DTCXCR4-tTA-expressing reporter cells (Fig. 5B). This provides
strong evidence that association between CXCR4 and b-arrestin2
absolutely depends on its cytoplasmic tail.
Interaction of b-arrestins and the phosphorylated CT tail of
GPCRs has been shown to cause agonist-induced receptor
internalization, a process considered as an important step in
signal desensitization [36]. As shown in Fig. 5C, for pro-B cells,
CXCL12 treatment induced internalization of 35–40% of cell
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50% was achieved at 60 min. On the contrary, CXCL12 binding
to DT did not trigger endocytosis at all. Interestingly, FL cells
downmodulated surface WT CXCR4 in response to CXCL12
with slower kinetics but stronger magnitude compared to that in
pro-B cells. Similar to that seen in mutant pro-B cells, there was no
obvious internalization of DT in FL cells 30 min after CXCL12
stimulation. However, after 2 h of CXCL12 incubation ,50% of
DT had been internalized in FL cells compared to 80% for WT
(Fig. 5D). Heterozygous DT mutant cells displayed an intermediate
Figure 1. Tail-truncated CXCR4 is able to bind CXCL12. (A) Snake-plot of mCXCR4 highlights two signaling modules, the DRY motif in green
and the serine and threonine residues in the CT tail of CXCR4 in orange. The arrowhead indicates the site of truncation in DT mice. (B) Histograms
show the expression of CXCR4 on WT (shaded histogram) or DT FL cells (red line) isolated from E18.5 embryos. The histogram with black line
represents isotype control. (C) Percentages of
125I-CXCL12 bound to HEK cells expressing WT CXCR4 (black curve) or DT (red curve) in the presence of
increasing concentrations of unlabelled CXCL12 (n=3, mean 6 SD).
doi:10.1371/journal.pone.0015397.g001
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seen in cells from some patients with WHIM syndrome [23].
Taken together, our data indicate that the truncation of the
CXCR4 tail severely compromises CXCL12-induced receptor
internalization in primary cells. The disparity in results observed
between FL and pro-B cells could be explained by FL cells
expressing CXCR7 that can form heterodimers with CXCR4
[37]. Therefore, internalization of ligand-bound CXCR7 could
result in partial downmodulation of heterodimerized DT, a process
that would not occur in pro-B cells which do not express CXCR7.
The CT tail is critical for CXCR4 G-protein-dependent and
-independent signaling
It remains to be determined whether signals initiated from G
proteins and the cytoplasmic tail-associated molecules may act
independently or must cross-talk to coordinately regulate proper
cellular functions. Therefore, we decided to use our DT mutant
cells to dissect the role of the CXCR4 tail in the CXCR4 signaling
cascade.
To obtain sufficient primary DT cells for biochemical studies,
we generated ROSA
ET2-CRE CXCR4-DT/F mice in which the
floxed Cxcr4 gene (Cxcr4
F) can be deleted by tamoxifen induced
Cre, allowing only DT expression in adult tissues (referred to as
conditional DT mice). Treatment of the conditional DT mice
with tamoxifen led to nearly complete deletion of the Cxcr4
F allele
in splenocytes, and the overall lymphoid and myeloid compart-
ments of the spleen in the mutant and WT mice were comparable
(data not shown). To determine whether the DT mutation
impaired CXCR4 signaling, we first examined activation ofERK
and PKB, which have been shown to be downstream of both b-
arrestin and G protein signaling pathways [38]. We found that
both ERK and PKB were rapidly and transiently phosphorylated
in WT cells after CXCL12 stimulation (Fig. 6A). This signaling
event was dependent on Gai protein activation, as PTX
treatment blocked their phosphorylation completely (Fig. 6B).
To our surprise, stimulation of DT splenocytes with CXCL12
failed to induce measurable levels of phosphorylation of either
ERK or PKB, suggesting that the lack of the CXCR4 tail impairs
G-protein activation (Fig. 6A). Similar results were also obtained
using FL cells and Abelson transformed pro-B cells (Fig. S5),
indicating that the observed defect in the activation of these
signaling pathways is a ubiquitous rather than a cell-lineage
specific phenomenon.
To further evaluate whether the tail contributed to CXCR4
mediated G-protein signaling, we examined CXCL12 induced
intracellular calcium mobilization, a key signaling event known to
be activated only by Gbc [39]. Surprisingly, we found that
CXCL12 stimulation was not able to elicit calcium flux in DT cells
(Fig. 6C). These results suggest that the CXCR4 tail may play an
essential role in G-protein activation.
CXCR4 mediated Gai protein activation is dependent on
the CXCR4 tail
Mutational studies showed that a cluster of amino acid residues
located at the N-terminal of the cytoplasmic tail of GPCRs was
critical for G-protein activation [40]. However, it is not clear
whether the CT tail was actually involved in G-protein coupling.
Since our data showed that DT failed to activate multiple signaling
pathways downstream of G proteins, we sought to determine
whether the DT mutation altered the physical interaction between
CXCR4 and heterotrimeric G proteins. We found that anti-
CXCR4 immunoprecipitated an equivalent amount of Gaii nW T
and DT cells (Fig. 7A), indicating that heterotrimeric G-proteins
are still physically associated with DT.
Although the CXCR4 tail was not required for G-protein
association, it may control G-protein activity. To assess this
Figure 3. CXCR4-mediated chemotaxis is abolished in mutant cells. (A) Transwell-assay measurement of CXCL12-induced chemotaxis of WT,
CXCR4-null and DT pro-B cells. Results obtained from three independent experiments are indicated as percent of total input. (*, P,0.0005, calculated
by the two-tailed Student’s t test). (B) E18.5 FL cells from WT, CXCR4-null and DT mice were subjected to CXCL12-induced chemotaxis. The migration
response is from a single experiment representative of at least three groups of embryos.
doi:10.1371/journal.pone.0015397.g003
Figure 2. DT mice display identical developmental defects to those in CXCR4 null mice. (A) Gross morphology of the E18.5 stomach of WT
and DT mice demonstrates that large vessels (arrow) were absent in DT mice. (B) Hematoxylin and eosin-stained sagittal sections of the E18.5
cerebellums show dislocated EGL cells (arrows) in mutant mice. (C) Contour plots reveal a reduced compartment of the B220
+CD43
+ pro-B cells in the
E18.5 DT FL. Numbers indicate percentages of cells within the indicated gate (mean 6 SD, n=7. *, P,0.0001, calculated by the two-tailed Student’s t
test). (D) Dot plots show that generation of myeloid lineage cells (Gr1
+CD11b
+) is normal in the FL but deficient in BM of E18.5 embryos. Values are
mean 6 the SD (n=3).
doi:10.1371/journal.pone.0015397.g002
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cAMP levels after CXCL12 stimulation. In WT cells, CXCL12-
activated Gai proteins inhibited forskolin-induced adenylyl cyclase
activity, leading to the suppression in intracellular cAMP
production. However, the forskolin elevated intracellular cAMP
level was not attenuated in DT cells after CXCL12 stimulation
(Fig. 7B). These data demonstrate that the CXCR4 tail, although
dispensable for G-protein association, is required for heterotri-
meric G-protein activation.
Discussion
Models regarding GPCR activation and signaling have been
rapidly modified to accommodate new data derived from
structural and mutational analysis of GPCRs. In a classical model,
GPCRs mediate virtually all signaling events through their
coupled G proteins, and the cytoplasmic tail of GPCRs plays
only a negative regulatory role through the interacting b-arrestins
to downmodulate ligand-activated receptors and desensitize cells
from further ligand stimulation [41]. This view has been changed
after the finding of ‘‘ligand bias’’, namely, a GPCR engaged to
different ligands can activate G proteins without inducing receptor
internalization or can activate downstream MAPK pathways
through b-arrestins in the absence of detectable G protein
activities [42–44]. In a revised model, different agonists may
induce the same GPCR to assume different active states, resulting
in exposure of distinct cytoplasmic interfaces to different
interacting molecules (the G proteins or b-arrestins) that
contribute to various cellular outcomes [45].
The physiological significance of these signaling mechanisms
has not been delineated in vivo. Here, we used CXCR4 as a model
molecule to elucidate the cellular effects mediated by individual
signaling modules of GPCRs. For this reason, we generated DT
mice. Our results demonstrate that the CXCR4 tail plays an
essential function of CXCR4 in the developing brain, vascular and
hematopoietic systems. However, the embryonic lethality of
CXCR4-DT mice was unexpected, as patients with WHIM
syndrome who also harbor truncating mutations at the CXCR4
C-terminus exhibited a dominant gain of function phenotype. We
speculate that C-terminus truncated CXCR4 in WHIM patients
might lose desensitization function but retain partial signaling
properties through the remaining 8 to 12 serine residues in its tail.
This postulation is supported by recent findings indicating that
site-specific phosphorylation of serine residues at the CXCR4 tail
is regulated by different GRKs which have either positive or
negative impact on CXCR4 signaling [33]. Further studies are
required to elucidate whether knock-in mice expressing the same
mutant form of CXCR4 as WHIM patients recapitulate the
human pathogenesis.
A question that remains unanswered is how the CXCR4 tail
facilitates G-protein activation. G proteins are presumably
activated through a cascade of conformational changes upon
ligand binding to GPCRs. Due to the high flexibility of the C-
terminus of GPCRs, this portion has been deleted to promote
crystallization of GPCRs for structural studies [46,47]. Therefore,
no information can be inferred from the available structures on the
interdependence between the C-terminus of GPCRs and GPCR-
associated G proteins. Based on biochemical studies, the tail of
GPCRs is known to interact with GRKs and b-arrestins. Although
it is unclear whether such an interaction facilitates G-protein
activation, experiments from b-arrestin2 and GRK6 knock-out
mice seem to suggest otherwise [48]. It is conceivable that the tail
itself or other unknown associated molecules may help to facilitate
the conformational change and activation of GPCR interacting
heterotrimeric G proteins upon ligand stimulation [49]. Further
mutagenesis and proteomics studies may help to resolve this issue.
It should be mentioned that DT embryos exhibited a relatively
milder developmental retardation as compared to the CXCR4-
null mice. Consistently, the DT mutation completely abolishes the
chemotaxis function but still retained the adhesion ability of WT
pro-B cells to VCAM-1 upon CXCL12 stimulation. These results
thus reveal the existence of a CT tail and G-protein independent
pathway responsible for CXCR4-induced inside-out signaling for
integrin activation. In agreement with this notion, it has been
Figure 4. DT largely restores the defective BM retention and
cell adhesion of CXCR4-null B-lineage precursors. (A) Peripheral
blood cells and splenocytes were isolated from 6 wk old WT, CD19-Cre+
CXCR4
f/f and CD19-Cre+ CXCR4
f/DT mice, and stained with anti-CD19,
B220 and IgM. CD19
+-gated cells can be further distinguished as B-cell
precursors (B220
loIgM
2) and mature B cell (B220
hiIgM
+) populations. Bar
graphs show percentages of B-cell precursors within the total CD19
+ B-
cell population detected in the periphery. Results were obtained from
5–8 mice of each group (*, P,0.001; **, P,0.000005, calculated by the
two-tailed Student’s t test). (B) CXCL12-stimulated WT, CXCR4-null and
DT pro-B cells were analyzed for their ability to adhere to VCAM-1. Data
are displayed as mean 6 SD from three independent experiments
(*, P,0.001; **, P,0.0005, calculated by the two-tailed Student’s t test).
doi:10.1371/journal.pone.0015397.g004
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CXCL12 (SDF) binding to CXCR4 stimulates recruitment of b-arrestin-TEV protease fusion protein (1). The TEV protease cleaves a recognition sequence
(highlighted in red) that has been fused, along with the transcriprion factor tTA, to the CT end of CXCR4 (2). This triggers the release of tTA (3)
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adhesion without evoking obvious G-protein signaling [50]. In the
case of CXCR4, we and others have found that PTX could
completely block CXCL12 induced chemotaxis but not adhesion
[51]. At present, the nature of this tail- and G protein-independent
pathway remains unclear.
In summary, we generated DT mice to directly determine the
signaling properties of the CXCR4 tail and to assess the
physiological relevance of this signaling module. Results from
our studies have revealed an unexpected regulatory role of the tail
in G-protein activation. This discovery is important not only for
understanding the mechanisms of GPCR activation and function
but is also pertinent for future drug development.
Materials and Methods
Ethics Statement
All experiments were reviewed and approved by the Institu-
tional Animal Care and Use Committee at the Feinstein Institute
for Medical Research (IACUC Protocol #2009-023).
Figure 6. Impaired signaling pathways in DT cells. (A) Splenocytes from conditional DT mice and their WT littermates were stimulated with
0.5 mg/ml CXCL12 for indicated times and immunoblot analysis for phosphorylated PKB at serine 473 (pPKB) or phosphorylated ERK (pERK) were
performed. Equal loading of protein was confirmed by anti-b-actin staining. Results are representative of at least 3 independent experiments. (B)W T
splenocytes, pretreated with 100 ng/ml of PTX for 1 h, were stimulated with 0.5 mg/ml of CXCL12 for 1 min and lysates immunoblotted for pERK and
re-probed with antibody against total ERK1/2 for loading control. (C) FL cells from WT, heterozygous and homozygous DT embryos were collected
and loaded with Fluo-4 and Fura-red calcium indicator dyes. Cells were stimulated with 0.5 mg/ml CXCL12 for 2 min followed by 2 mM ionomycin.
Results are representative of 3 independent experiments.
doi:10.1371/journal.pone.0015397.g006
allowing it to enter the nucleus and activate the expression of the tTA-dependent luciferase reporter gene (4). (B) HEK cells were transiently
transfected with the luciferase reporter vector together with a combination of b-arrestin-TEV, WTCXCR4-tTA, or DTCXCR4-tTA as indicated. Cells were
stimulated with CXCL12 and measured for luciferase activity. Results from 3 independent experiments are displayed as the luminescence index
calculated by the fold increases in luciferase activity in cells 6 CXCL12 (*, P,0.01, calculated using the two-tailed Students t test). (C) The kinetics of
receptor downmodulation was determined by measuring cell-surface expression of WT CXCR4 or DT on pro-B cells after CXCL12 stimulation for
indicated times. Results are from 3 independent experiments (*, P,0.05, calculated using the two-tailed Student’s t test). (D) CXCL12-induced
receptor internalization on E18.5 FL cells was carried out as described in (C) above. (E) Representative histograms show CXCR4 expression on FL cells
of WT, heterozygous and homozygous DT mice with (thick line) or without (shaded) 2 h CXCL12 incubation.
doi:10.1371/journal.pone.0015397.g005
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Strategies for gene targeting, ES cell screening and genotyping
of DT mice are provided in Fig. S1. To generate mice that express
DT in adult tissues, DT mice were bred to previously described
ROSA
ET2-CRE Cxcr4
+/F mice [52] to obtain conditional DT mice
(ROSA
ET2-CRE CXCR4-DT/F) and littermate controls (CXCR4-
DT/F). To express DT specifically in B-lineage cells, DT mice
were bred to CD19-Cre Cxcr4
+/F mice to generate CD19-Cre+
CXCR4-DT/F mice. Previously reported CXCR4-null mice were
used as negative controls.
Abelson virus transformation of pro-B cells
FL cells were isolated from E15.5 WT and DT embryos and
incubated with Abelson virus suspensions (gift from Dr. Hua Gu,
Columbia University) for 2 h, 37uC. Cells were then cultured in
OptiMEM + 10% FBS. 7 d later, cells underwent a second round
of Abelson virus infection. CXCR4-null pro-B cell lines were
generated by infecting splenocytes of CXCR4
f/fCD19-Cre mice
with Abelson virus. Primary transformants were analyzed by flow
cytometry and confirmed to be a homogenous population of
B220
+CD43
+ pro-B cells.
Histology
Histology analysis was performed as described [4]. Briefly,
brains of E18.5 embryos were dissected, fixed in Bouin’s solution
and embedded in paraffin. 6 mm brain sections were stained with
hematoxylin and eosin and analyzed under a Nikon Eclipse
TE2000-E microscope equipped with a Nikon DS-Fi1 color
camera.
Flow cytometry and receptor internalization
Cells from the PB, spleen or FL were stained using following
antibodies: anti-B220 APC, anti-CD43 FITC, anti-CD19 PE,
anti-Gr-1 PE, anti-CD11b FITC and anti-IgM FITC (all from
eBioscience). Data were attained on an LSR II (Becton Dickinson)
and analyzed using FlowJo software (Tree Star).
For receptor internalization analysis, cells were resuspended at
4610
6 cells/ml in DMEM and stimulated with 0.5 mg/ml
CXCL12 at 37uC. Reactions were terminated by addition of 4%
PFA. Cells were stained for surface CXCR4 with anti-CXCR4
biotin (BD) and streptavidin-conjugated PE-Cy7 (eBioscience).
CXCR4 downmodulation was determined based on the mean
fluorescent intensity (MFI) of CXCR4 expression with the
following formula: % downmodulation =100 x {(MFI of
unstimulated cells (at time t) – MFI of stimulated cells (at time
t))/MFI of unstimulated cells (at time 0)}.
Chemotaxis and adhesion assays
Chemotaxis was performed in transwells (5 mM pore size,
Costar). The upper chambers containing 2610
5 cells were placed
into lower wells with 0.5 mg/ml CXCL12 (Peprotech). After 3 h
incubation at 37uC, migrated cells were collected and enumerated
by flow cytometry.
Adhesion assays were done as previously described [53]. Briefly,
96-well plates (Greiner) were coated with 1 mg/ml rmVCAM-1-Fc
(R&D Systems) and CXCL12 (0.5 mg/ml). Wells were blocked
with PBS +2% BSA and 50 mg/ml heparin sulphate. Pro-B cells
were seeded at 3610
5 cells/well and incubated at 37uC, 2 min.
Non-adherent cells were removed by washing and adherent cells
counted by flow cytometry.
Calcium mobilization
5610
5 FL cells from E18.5 embryos in 0.5 ml of assay buffer
(25 mM HEPES, pH 7.4, 0.1% BSA, 2.5 mM probenecid in
Hank’s buffer) were loaded for 30 min at 37uC with 2 mM Fluo-4
and 0.84 mM Fura-red (Molecular Probes). Cells were then
washed and resuspended in pre-warmed assay buffer. Samples
were first analyzed by flow cytometry for 1 min to establish a
baseline before stimulation with 0.5 mg/ml CXCL12 for 2 min
and then 2 mM ionomycin (Sigma) for another 2 min.
Immunoprecipitation and immunoblotting
To detect interaction between CXCR4 and G-proteins, WT,
CXCR4-null and DT pro-B cells were serum-starved for 2 h at
37uC and then cross-linked with 1 mM DSP (dithio-bis-succini-
midyl propionate, Pierce) for 30 min, RT. Then cells were lysed
by addition of lysis buffer (0.1 M NaCl, 50 mM Tris-HCl, pH 7.4,
15 mM EGTA, 1% SDS, 1% Triton X-100, 1% Cymal-5, 50 mg/
ml DNase I, and protease inhibitors (Roche)). Lysates were
centrifuged and cleared samples incubated with 10 mg/ml anti-
CXCR4 (Abcam) overnight, 4uC, and then with 30 ml protein G
agarose for an additional 3 h. Beads were washed, eluted in
2x SDS sample buffer, resolved by 4–12% gradient SDS-PAGE,
and analyzed by immunoblotting with anti-Gai (Santa Cruz
Biotechnology).
Figure 7. The CXCR4 tail is essential for G-protein activation
but not association. (A)W Ta n dDT pro-B cell lysates were
immunoprecipitated with anti-CXCR4 antibody and immunoblotted
for Gai. (B) Splenocytes from WT and conditional DT mice were used for
assessment of Gai activities measured by CXCL12-induced inhibition of
intracellular cAMP production. The cAMP levels in untreated cells (open
bars), in cells stimulated with 1 mg/ml of CXCL12 for 10 min (gray bars),
in cells pretreated with 1 mM forskolin (FSK, black bars) and in cells
treated with FSK and CXCL12 (hatched bars) were determined by
ELISA.
doi:10.1371/journal.pone.0015397.g007
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DT mice and littermate controls were stimulated with 0.5 mg/ml
CXCL12 for indicated times and immunoblots prepared from
lysates. Western blot analysis was carried out with antibodies
against pPKB (S473, Cell Signaling), ERK and pERK (Thr202,
Tyr204) (Santa Cruz Biotechnology).
Radioligand binding assay
HEK cells stably transfected with WT CXCR4 or DT were
used in a standard competitive radioligand binding assay. Briefly,
cells were incubated for 2 hr at 4uC with 187 pM
125I-CXCL12
(PerkinElmer) in the presence of increasing concentrations of cold
CXCL12 (0–1000 nM). After washing 3 times in wash buffer
(0.5 M NaCl, 1% BSA, 5 mM MgCl2, 1 mM CaCl2,2 5m M
HEPES, pH 7.1), bound radioactivity was measured using a b
counter (Beckman LS 6500SC). Data were averaged from three
independent experiments, and calculated as: % of binding =100 x
{(cpmnon-comp. – cpmsample)/cpmnon-comp.}
Intracellular cAMP assay
Splenocytes isolated from conditional DT mice and controls
were starved in serum-free medium for 1 h at 37uC. After
incubation with 1 mM 3-isobutyl-1-methylxanthine (IBMX) at
37uC for 10 min, cells were stimulated with 1 mg/ml CXCL12 for
10 min, followed by 10 min incubation in the presence of 1 mM
forskolin. Intracellular cAMP levels were determined using a
competitive enzyme immunoassay (Amersham) following the
manufacturer’s instructions.
Tango assay
Plasmids b-arrestin-TEV and VTT (TEV cleavage site-tTA
fusion construct) were kindly provided by the Richard Axel lab
(Columbia University). Luciferase reporter vector (pBI-GI) was
from Invitrogen. WT CXCR4 and DT were obtained by PCR
using primers outlined in Text S1, and cloned into the VTT
plasmid to generate WT or DT fused to the TEV cleavage site
ENLYFQL followed by tTA (plasmids WTCXCR4-tTA or
DTCXCR4-tTA).
HEK cells were plated into a 96-well flat-bottomed plate at
50,000 cells/well and transfected with b-arrestin-TEV,
WTCXCR4-tTA or DTCXCR4-tTA, and pBI-GI at a ratio of
1:5:1 and incubated overnight at 37uC. Supernatant was then
replaced with fresh DMEM 61 mg/ml CXCL12 and incubated
for 6 hr, 37uC. Media was aspirated and BrightGlo luciferase
substrate (Promega) added to each well and activity measured by a
Berthold TriStar LB941 plate reader.
Supporting Information
Figure S1 Generation of Mutant Mice. (A) Structure of the
wildtype Cxcr4 locus, map of the targeting construct, the targeted
Cxcr4 allele before and after Cre/loxP-mediated neo gene deletion.
The tail-truncation mutation was introduced into the second exon
by PCR (Exon II). (B) Southern blot analysis of tail DNA from
wildtype, heterozygous mice carrying both the mutated exon II
and the neo gene (+/2), and heterozygous mice carrying mutant
Cxcr4 allele after neo gene deletion (+/mu). The allele detected by
probe a: wildtype or mutant Cxcr4 allele without the neo gene:
3.8 kb; the mutant Cxcr4 allele with the neo gene: 5.0 kb. The allele
detected by probe b: wildtype: 7.2 kb; the mutant Cxcr4 allele with
or without the neo gene: 4.9 kb. The following PCR primers are
used for genotyping, which produces a 405-bp wildtype band and
a 303-bp tail-truncated Cxcr4 band: 005-D59:5 9-CTTCTT-
CCACTGTTGCCTGAACC-39 005-D3-end: 59- GCCA-
CAGGTCCCTGCCTAGAC-39 (TIF)
Figure S2 B cell precursors in the spleen and peripheral
blood. Splenocytes and peripheral blood cells were isolated from
6-week-old wildtype (DT/F), CD19-Cre+ CXCR4
F/DT (DT/-)
and CD19-Cre+ CXCR4
F/F (2/2) mice and stained with
antibodies against CD19, B220 and IgM. CD19
+-gated cells were
plotted with IgM and B220. Numbers (mean 6 SD) represent
percentages of B220
loIgM
2 B-cell precursors within the CD19
+ B-
cell population (n=5–8). (TIF)
Figure S3 Expression of CXCR4, CXCR7 and CD29 in
pro-B cells. (A) Cell surface expression of VLA-4 (a4b1) on
Abelson-transformed pro-B cells derived from the wildtype (shaded)
and CXCR4-DT mice (red line) were detected with anti-CD29
(integrin b1) and analyzed by flow cytometry. (B) Cell surface
expression of CXCR4 on Abelson-transformed pro-B cells derived
from wildtype, CXCR4-null and CXCR4-DT mice. (C) Expression
of CXCR7 was determined by qRT-PCR. RNA was purified
from fetal liver cells of E18.5 wildtype (WT) or CXCR7
2/2
embryos, bone marrow cells of wildtype 8-week-old mice, or
Abelson-transformed WT pro B cells using an RNeasy kit (Qiagen).
cDNA was then prepared using SuperScriptIII First Strand
Synthesis kit (Invitrogen). qRT-PCR was performed using primers
specific for CXCR7. Each value was normalized to b-actin
expression levels. (TIF)
Figure S4 Pro-B cell adhesion to VCAM-1 is insensitive
to pertussis toxin treatment. Pro-B cells were treated with
100 ng/ml of pertussis toxin (PTX) for 3 h at 37uC. PTX-treated
and untreated cells were respectively seeded in 96-well plates
coated with 1 mg/ml of mouse VCAM-1-Fc with or without
0.5 mg/ml of CXCL12, and incubated at 37uC for an additional
2 min. Non-adherent cells were then removed by washing,
adherent cells were collected and counted. Bar graphs represent
the percentages of pro-B cells attached to VCAM-1 in the
presence or absence of PTX. Wildtype and CXCR4-DT cells are
indicated by open and gray bars, respectively. (TIF)
Figure S5 Impaired signaling in CXCR4 CXCR4-DT
pro-B cells. Abelson-transformed pro-B cells were stimulated
with 0.5 mg/ml CXCL12 for indicated times. Cell lysates were
prepared and Western blot analysis for phosphorylated PKB at
serine 473 (pPKB) or phosphorylated ERK (pERK) were
performed. Equal loading of protein was confirmed by re-blotting
with anti-ERK antibody. Results are representative of at least 3
independent experiments. (TIF)
Text S1 Primers. (DOC)
Acknowledgments
The authors thank all Zou lab members for discussions; J. Liao for
genotyping mice; R. Clynes for help in ligand-binding assay; H. Gu for
Abelson virus supernatant.
Author Contributions
Conceived and designed the experiments: DC YZ. Performed the
experiments: DC YN YZ. Analyzed the data: DC YZ. Contributed
reagents/materials/analysis tools: JW YZ. Wrote the paper: DC YZ.
References
1. Murdoch C (2000) CXCR4: Chemokine Receptor Extraordinaire. Immunol
Rev 177: 175–184.
2. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, et al. (1996)
Defects Of B-Cell Lymphopoiesis And Bone-Marrow Myelopoiesis In
The Function of the CXCR4 Cytoplasmic Tail
PLoS ONE | www.plosone.org 10 November 2010 | Volume 5 | Issue 11 | e15397Mice Lacking The CXC Chemokine PBSF/SDF-1. Nature 382: 635–
638.
3. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, et al. (1998) The
Chemokine Receptor CXCR4 Is Essential For Vascularization Of The
Gastrointestinal Tract. Nature 393: 591–594.
4. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function
Of The Chemokine Receptor CXCR4 In Haematopoiesis And In Cerebellar
Development. Nature 393: 595–599.
5. Bagri A, Gurney T, He X, Zou YR, Littman DR, et al. (2002) The Chemokine
SDF1 Regulates Migration Of Dentate Granule Cells. Development 129:
4249–4260.
6. Lieberam I, Agalliu D, Nagasawa T, Ericson J, Jessell TM (2005) A Cxcl12-
CXCR4 Chemokine Signaling Pathway Defines The Initial Trajectory Of
Mammalian Motor Axons. Neuron 47: 667–679.
7. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, et al. (2000) Stromal
Cell-Derived Factor-1-CXC Chemokine Receptor 4 Interactions Play A Central
Role In CD4+ T Cell Accumulation In Rheumatoid Arthritis Synovium.
J Immunol 165: 6590–6598.
8. Lukacs NW, Berlin A, Schols D, Skerlj RT, Bridger GJ (2002) AMD3100, A
Cxcr4 Antagonist, Attenuates Allergic Lung Inflammation And Airway
Hyperreactivity. Am J Pathol 160: 1353–1360.
9. Zlotnik A (2006) Chemokines And Cancer. Int J Cancer 119: 2026–2029.
10. Burger JA, Kipps TJ (2006) CXCR4: A Key Receptor In The Crosstalk Between
Tumor Cells And Their Microenvironment. Blood 107: 1761–1767.
11. Gether U, Kobilka BK (1998) G Protein-Coupled Receptors. II. Mechanism Of
Agonist Activation. J Biol Chem 273: 17979–17982.
12. Meng EC, Bourne HR (2001) Receptor Activation: What Does The Rhodopsin
Structure Tell Us? Trends Pharmacol Sci 22: 587–593.
13. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ (1991) Model Systems For
The Study Of Seven-Transmembrane-Segment Receptors. Annu Rev Biochem
60: 653–688.
14. Savarese TM, Fraser CM (1992) In Vitro Mutagenesis And The Search For
Structure-Function Relationships Among G Protein-Coupled Receptors.
Biochem J 283(Pt 1): 1–19.
15. Moepps B, Frodl R, Rodewald HR, Baggiolini M, Gierschik P (1997) Two
Murine Homologues Of The Human Chemokine Receptor CXCR4 Mediating
Stromal Cell-Derived Factor 1alpha Activation Of Gi2 Are Differentially
Expressed In Vivo. Eur J Immunol 27: 2102–2112.
16. Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou CL, et al. (1997)
Molecular Uncoupling Of C-C Chemokine Receptor 5-Induced Chemotaxis
And Signal Transduction From HIV-1 Coreceptor Activity. Proc Natl Acad
Sci U S A 94: 5061–5066.
17. Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper SC, et al. (1997)
Regulation Of Human Chemokine Receptors CXCR4. Role Of Phosphoryla-
tion In Desensitization And Internalization. J Biol Chem 272: 28726–28731.
18. Signoret N, Rosenkilde MM, Klasse PJ, Schwartz TW, Malim MH, et al. (1998)
Differential Regulation Of CXCR4 And CCR5 Endocytosis. J Cell Sci 111(Pt
18): 2819–2830.
19. Krupnick JG, Benovic JL (1998) The Role Of Receptor Kinases And Arrestins
In G Protein-Coupled Receptor Regulation. Annu Rev Pharmacol Toxicol 38:
289–319.
20. Ferguson SS (2001) Evolving Concepts In G Protein-Coupled Receptor
Endocytosis: The Role In Receptor Desensitization And Signaling. Pharmacol
Rev 53: 1–24.
21. Lefkowitz RJ, Shenoy SK (2005) Transduction Of Receptor Signals By Beta-
Arrestins. Science 308: 512–517.
22. Diaz GA (2005) CXCR4 Mutations In WHIM Syndrome: A Misguided
Immune System? Immunol Rev 203: 235–243.
23. Kawai T, Choi U, Whiting-Theobald NL, Linton GF, Brenner S, et al. (2005)
Enhanced Function With Decreased Internalization Of Carboxy-Terminus
Truncated CXCR4 Responsible For WHIM Syndrome. Exp Hematol 33:
460–468.
24. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, et al. (2003)
Mutations In The Chemokine Receptor Gene CXCR4 Are Associated With
WHIM Syndrome, A Combined Immunodeficiency Disease. Nat Genet 34:
70–74.
25. Ueda Y, Neel NF, Schutyser E, Raman D, Richmond A (2006) Deletion Of The
COOH-Terminal Domain Of CXC Chemokine Receptor 4 Leads To The
Down-Regulation Of Cell-To-Cell Contact, Enhanced Motility And Prolifera-
tion In Breast Carcinoma Cells. Cancer Res 66: 5665–5675.
26. Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, et al. (2008)
CXCR4 Dimerization And Beta-Arrestin-Mediated Signaling Account For The
Enhanced Chemotaxis To CXCL12 In WHIM Syndrome. Blood 112: 34–44.
27. Mccormick PJ, Segarra M, Gasperini P, Gulino AV, Tosato G (2009) Impaired
Recruitment Of Grk6 And Beta-Arrestin 2 Causes Delayed Internalization And
Desensitization Of A WHIM Syndrome-Associated CXCR4 Mutant Receptor.
Plos One 4: E8102.
28. Roland J, Murphy BJ, Ahr B, Robert-Hebmann V, Delauzun V, et al. (2003)
Role Of The Intracellular Domains Of CXCR4 In SDF-1-Mediated Signaling.
Blood 101: 399–406.
29. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, et al. (1998) Impaired
B-Lymphopoiesis, Myelopoiesis, And Derailed Cerebellar Neuron Migration In
CXCR4- And SDF-1-Deficient Mice. Proc Natl Acad Sci U S A 95: 9448–9453.
30. Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, et al. (2004) The Role Of
CXCR4 In Maintaining Peripheral B Cell Compartments And Humoral
Immunity. J Exp Med 200: 1145–1156.
31. Leuker CE, Labow M, Muller W, Wagner N (2001) Neonatally Induced
Inactivation Of The Vascular Cell Adhesion Molecule 1 Gene Impairs B Cell
Localization And T Cell-Dependent Humoral Immune Response. J Exp Med
193: 755–768.
32. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, et al. (2001) Conditional
Vascular Cell Adhesion Molecule 1 Deletion In Mice: Impaired Lymphocyte
Migration To Bone Marrow. J Exp Med 193: 741–754.
33. Busillo JM, Armando S, Sengupta R, Meucci O, Bouvier M, et al. (2010) Site-
Specific Phosphorylation Of CXCR4 Is Dynamically Regulated By Multiple
Kinases And Results In Differential Modulation Of CXCR4 Signaling. J Biol
Chem 285: 7805–7817.
34. Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, et al. (2000) Beta-Arrestin
Differentially Regulates The Chemokine Receptor CXCR4-Mediated Signaling
And Receptor Internalization, And This Implicates Multiple Interaction Sites
Between Beta-Arrestin And CXCR4. J Biol Chem 275: 2479–2485.
35. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, et al. (2008) The Genetic
Design Of Signaling Cascades To Record Receptor Activation. Proc Natl Acad
Sci U S A 105: 64–69.
36. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-Transmembrane
Receptors. Nat Rev Mol Cell Biol 3: 639–650.
37. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B (2009) CXCR7
Heterodimerizes With CXCR4 And Regulates CXCL12-Mediated G Protein
Signaling. Blood 113: 6085–6093.
38. Luttrell LM, Daaka Y, Lefkowitz RJ (1999) Regulation Of Tyrosine Kinase
Cascades By G-Protein-Coupled Receptors. Curr Opin Cell Biol 11: 177–183.
39. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, et al.
(2003) Insights Into G Protein Structure, Function, And Regulation. Endocr Rev
24: 765–781.
40. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, et al.
(2007) GPCR Engineering Yields High-Resolution Structural Insights Into
Beta2-Adrenergic Receptor Function. Science 318: 1266–1273.
41. Lefkowitz RJ (1998) G Protein-Coupled Receptors. III. New Roles For Receptor
Kinases And Beta-Arrestins In Receptor Signaling And Desensitization. J Biol
Chem 273: 18677–18680.
42. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, et al. (2004)
Differential Desensitization, Receptor Phosphorylation, Beta-Arrestin Recruit-
ment, And ERK1/2 Activation By The Two Endogenous Ligands For The CC
Chemokine Receptor 7. J Biol Chem 279: 23214–23222.
43. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, et al. (2003) Independent
Beta-Arrestin 2 And G Protein-Mediated Pathways For Angiotensin II
Activation Of Extracellular Signal-Regulated Kinases 1 And 2. Proc Natl Acad
Sci U S A 100: 10782–10787.
44. Colvin RA, Campanella GS, Sun J, Luster AD (2004) Intracellular Domains Of
CXCR3 That Mediate CXCL9, CXCL10, And CXCL11 Function. J Biol
Chem 279: 30219–30227.
45. Violin JD, Lefkowitz RJ (2007) Beta-Arrestin-Biased Ligands At Seven-
Transmembrane Receptors. Trends Pharmacol Sci 28: 416–422.
46. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, et al.
(2007) High-Resolution Crystal Structure Of An Engineered Human Beta2-
Adrenergic G Protein-Coupled Receptor. Science 318: 1258–1265.
47. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, et al. (2007)
Crystal Structure Of The Human Beta2 Adrenergic G-Protein-Coupled
Receptor. Nature 450: 383–387.
48. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, et al. (2002)
Defective Lymphocyte Chemotaxis In Beta-Arrestin2- And GRK6-Deficient
Mice. Proc Natl Acad Sci U S A 99: 7478–7483.
49. Ding Y, Zhang L, Goodwin JS, Wang Z, Liu B, et al. (2008) Plectin Regulates
The Signaling And Trafficking Of The HIV-1 Co-Receptor CXCR4 And Plays
A Role In HIV-1 Infection. Exp Cell Res 314: 590–602.
50. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, et al. (2006) A
Novel Chemokine Receptor For SDF-1 And I-TAC Involved In Cell Survival,
Cell Adhesion, And Tumor Development. J Exp Med 203: 2201–2213.
51. Mazo IB, Honczarenko M, Leung H, Cavanagh LL, Bonasio R, et al. (2005)
Bone Marrow Is A Major Reservoir And Site Of Recruitment For Central
Memory CD8+ T Cells. Immunity 22: 259–270.
52. Nie Y, Han YC, Zou YR (2008) CXCR4 Is Required For The Quiescence Of
Primitive Hematopoietic Cells. J Exp Med 205: 777–783.
53. De Gorter DJ, Beuling EA, Kersseboom R, Middendorp S, Van Gils JM, et al.
(2007) Bruton’s Tyrosine Kinase And Phospholipase Cgamma2 Mediate
Chemokine-Controlled B Cell Migration And Homing. Immunity 26: 93–104.
The Function of the CXCR4 Cytoplasmic Tail
PLoS ONE | www.plosone.org 11 November 2010 | Volume 5 | Issue 11 | e15397